Overview
Updated 14 Jul 2026
Andrzej Jakubowiak is Professor of Medicine, Director of the Myeloma Program at University of Chicago, Department of Medicine, Section of Hematology/Oncology. The public record shows 477 publications with 23,306 citations (h-index 68), centered on Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, CAR-T cell therapy research. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 16 companies.
- Most recent indexed publication: 2026 · Science translational medicine
- Top research focus: Multiple Myeloma Research and Treatments
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 214.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
Sponsor: University of Chicago
InvestigatorPhase 3Active, not recruitingNCT03729804 - Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
Sponsor: University of Chicago
InvestigatorPhase 2CompletedNCT02969837 - Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Sponsor: University of Chicago
InvestigatorPhase 3Active, not recruitingNCT02659293
Industry payments
Updated 14 Jul 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
- Adaptive Biotechnologies CorporationProgram year20252 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Jul 2026
113 congress contributions (2006–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
- B cell kinetics on next generation sequencing after CAR T-cell therapy in multiple myeloma
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.
Science translational medicine
2026
Most-cited worksby citation count (OpenAlex)
- 02Initial genome sequencing and analysis of multiple myeloma1,440 citations2011
- 03Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma1,325 citations2014
- 04
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
5841 S. Maryland Avenue, Chicago, IL 60637
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- MD
Poznan University of Medical Sciences, Poland
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu ↗ - PhD
Poznan University of Medical Sciences, Poland
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu ↗ - Board Certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uchicagomedicine.org ↗
Editorial & leadership rolesjournal and society appointments
- Lead investigator
multiple multi-site clinical trials in newly diagnosed, relapsed, and refractory multiple myeloma
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nature.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu ↗
Secondary affiliationsappointments beyond the home institution
- Duchossois Center for Advanced Medicine
UChicago Medicine (clinical practice location)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthtree.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/andrzej-jakubowiak-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/andrzej-jakubowiak-a018a96a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - X / Twitter
x.com/ajjakubowiak
Mentions by otherswhere others cite or feature them
- Other
onclive.com/authors/andrzej-jakubowiak-md-phd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - X / Twitter
x.com/UCCancerCenter/status/1929204488692175235
- X / Twitter
x.com/UCCancerCenter/status/2034681581449650233
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
- 1,236
- publications
- 120
- h-index
- 23
- trials
Mary Rinella, MD
University of Chicago
- 279
- publications
- 71
- h-index
- 4
- trials
Jay Koyner, MD
University of Chicago
- 478
- publications
- 58
- h-index
- 7
- trials
Seenu Hariprasad, MD
University of Chicago
- 284
- publications
- 33
- h-index
- 2
- trials